HYDROCORTISONE 1%

HYDROCORTISONE 1% was reported 68278 times

HYDROCORTISONE 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 113 0.5979
1 VAGINAL FLATULENCE 138 0.4554
2 LYMPHOID TISSUE HYPOPLASIA 68 0.4444
3 THYMUS HYPOPLASIA 73 0.4195
4 C-REACTIVE PROTEIN 353 0.3808
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 754 0.3764
6 GRIP STRENGTH 86 0.3755
7 TOPICAL STEROID WITHDRAWAL REACTION 146 0.3753
8 LUPUS VULGARIS 456 0.3619
9 RHEUMATIC FEVER 1547 0.3467
10 SWOLLEN JOINT COUNT INCREASED 1089 0.3412
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 225 0.3368
12 FACET JOINT SYNDROME 1069 0.3280
13 SWOLLEN JOINT COUNT 72 0.2880
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 592 0.2854
15 CYSTITIS BACTERIAL 96 0.2840
16 NOROVIRUS TEST POSITIVE 88 0.2708
17 DISLOCATION OF VERTEBRA 579 0.2536
18 DUODENAL ULCER PERFORATION 1885 0.2532
19 X-RAY ABNORMAL 452 0.2525
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1785 0.2489
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 139 0.2478
22 STEROID DEPENDENCE 216 0.2460
23 RHEUMATOID FACTOR POSITIVE 1395 0.2413
24 STEROID WITHDRAWAL SYNDROME 242 0.2368
25 CRANIOPHARYNGIOMA 75 0.2259
26 ADRENOCORTICAL INSUFFICIENCY ACUTE 426 0.2181
27 MYCOBACTERIUM CHELONAE INFECTION 155 0.2097
28 RETINITIS 362 0.2094
29 APPENDICOLITH 79 0.2041
30 ANALGESIC THERAPY 63 0.1963
31 HYPOCHOLESTEROLAEMIA 69 0.1955
32 PERIPHERAL VENOUS DISEASE 782 0.1913
33 SECONDARY IMMUNODEFICIENCY 229 0.1885
34 CATARRH 169 0.1869
35 ABSCESS BACTERIAL 66 0.1818
36 HELICOBACTER INFECTION 1865 0.1813
37 ADRENAL SUPPRESSION 149 0.1767
38 PEMPHIGUS 2059 0.1645
39 C-REACTIVE PROTEIN ABNORMAL 1036 0.1613
40 PORPHYRIA ACUTE 230 0.1603
41 MUSCLE INJURY 1300 0.1567
42 HAND DEFORMITY 2014 0.1534
43 FOLLICULITIS 1537 0.1464
44 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 934 0.1437
45 CORONA VIRUS INFECTION 60 0.1395
46 OVERLAP SYNDROME 96 0.1371
47 HYPOFIBRINOGENAEMIA 128 0.1290
48 BREAST CANCER STAGE III 832 0.1283
49 PERICARDITIS 2058 0.1224
50 SYNOVITIS 2098 0.1162
51 LIP DRY 1036 0.1139
52 PSEUDOMONAL SEPSIS 197 0.1124
53 SERONEGATIVE ARTHRITIS 125 0.1091
54 ONYCHOMADESIS 454 0.1081
55 DRUG TOLERANCE DECREASED 299 0.1064
56 FEMALE GENITAL TRACT FISTULA 181 0.1059
57 PARAINFLUENZAE VIRUS INFECTION 150 0.0985
58 FEBRILE BONE MARROW APLASIA 410 0.0964
59 GRIP STRENGTH DECREASED 840 0.0953
60 ONYCHOMYCOSIS 418 0.0952
61 GLOSSODYNIA 2112 0.0942
62 HYPERCHOLESTEROLAEMIA 910 0.0942
63 BURNS SECOND DEGREE 165 0.0940
64 JOINT RANGE OF MOTION DECREASED 1250 0.0931
65 LIVE BIRTH 765 0.0914
66 HUMAN HERPESVIRUS 6 INFECTION 168 0.0888
67 BONE EROSION 309 0.0873
68 BURSITIS 1040 0.0856
69 WOUND INFECTION 936 0.0854
70 SECONDARY ADRENOCORTICAL INSUFFICIENCY 124 0.0821
71 GRAFT LOSS 59 0.0814
72 DEATH NEONATAL 113 0.0812
73 WOUND 2222 0.0794
74 ENTEROBACTER INFECTION 133 0.0791
75 ADRENAL INSUFFICIENCY 939 0.0773
76 BLEPHAROSPASM 483 0.0766
77 AUTOIMMUNE DISORDER 736 0.0754
78 RADICULOPATHY 188 0.0713
79 IRRITABLE BOWEL SYNDROME 1509 0.0703
80 BODY TEMPERATURE FLUCTUATION 145 0.0695
81 SYSTEMIC LUPUS ERYTHEMATOSUS 2437 0.0686
82 FIBROMYALGIA 1649 0.0678
83 VIRAEMIA 93 0.0671
84 DIABETES INSIPIDUS 158 0.0656
85 PROCTITIS 183 0.0653
86 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
87 DRUG LEVEL BELOW THERAPEUTIC 356 0.0645
88 CHRONIC SINUSITIS 238 0.0633
89 PITUITARY TUMOUR BENIGN 99 0.0607
90 TYPE 2 DIABETES MELLITUS 1946 0.0577
91 LIVER INJURY 1374 0.0559
92 NAIL DISORDER 483 0.0551
93 HYPOPITUITARISM 96 0.0551
94 SKIN WEEPING 196 0.0549
95 CORTISOL DECREASED 62 0.0542
96 CYTOMEGALOVIRUS CHORIORETINITIS 105 0.0538
97 OBESITY 849 0.0532
98 INFUSION RELATED REACTION 3503 0.0528
99 FINGER DEFORMITY 256 0.0528
100 SCIATICA 840 0.0526
101 CONTRAINDICATED PRODUCT ADMINISTERED 1595 0.0526
102 PRODUCT LABEL CONFUSION 305 0.0523
103 FAECAL CALPROTECTIN INCREASED 165 0.0521
104 MATERNAL EXPOSURE TIMING UNSPECIFIED 192 0.0511
105 HYPOPNOEA 174 0.0501
106 BRONCHIECTASIS 332 0.0492
107 IMPAIRED HEALING 1604 0.0488
108 RHINOVIRUS INFECTION 190 0.0488
109 HYPOPHYSITIS 98 0.0487
110 PNEUMATOSIS INTESTINALIS 137 0.0480
111 PUSTULAR PSORIASIS 163 0.0474
112 GASTROENTERITIS NOROVIRUS 63 0.0474
113 PULMONARY FIBROSIS 904 0.0471
114 EXOSTOSIS 428 0.0468
115 BLOOD PRESSURE FLUCTUATION 1088 0.0453
116 ULCER HAEMORRHAGE 304 0.0449
117 PSORIATIC ARTHROPATHY 1816 0.0447
118 LOWER LIMB FRACTURE 834 0.0434
119 ANAL FISSURE 232 0.0432
120 EYE INJURY 131 0.0431
121 APLASTIC ANAEMIA 222 0.0425
122 STRONGYLOIDIASIS 68 0.0421
123 PRESCRIBED OVERDOSE 809 0.0418
124 WALKING AID USER 275 0.0417
125 ADRENAL DISORDER 80 0.0416
126 CONGENITAL ANOMALY 315 0.0407
127 INTENTIONAL PRODUCT USE ISSUE 3539 0.0404
128 LOWER RESPIRATORY TRACT INFECTION 1830 0.0402
129 ALCOHOL POISONING 106 0.0395
130 NORMAL NEWBORN 214 0.0393
131 LUPUS-LIKE SYNDROME 357 0.0393
132 COELIAC DISEASE 386 0.0393
133 BLOOD CHOLESTEROL INCREASED 1810 0.0388
134 RASH VESICULAR 187 0.0386
135 BREAST CANCER STAGE II 315 0.0378
136 CUSHINGOID 121 0.0377
137 DRUG LEVEL ABOVE THERAPEUTIC 170 0.0371
138 HYPERPHOSPHATAEMIA 79 0.0367
139 RED BLOOD CELL SEDIMENTATION RATE INCREASED 405 0.0366
140 ARTHROPATHY 2027 0.0364
141 GAIT INABILITY 1203 0.0360
142 BACK INJURY 388 0.0356
143 BLOOD PRESSURE DIASTOLIC DECREASED 259 0.0351
144 BRONCHOPULMONARY ASPERGILLOSIS 271 0.0349
145 BLISTER 1945 0.0346
146 PRESCRIBED UNDERDOSE 681 0.0341
147 SERUM SICKNESS 95 0.0341
148 BLOOD PHOSPHORUS INCREASED 92 0.0337
149 HEPATIC ENZYME INCREASED 2261 0.0331
150 ASPERGILLUS INFECTION 216 0.0329
151 POOR VENOUS ACCESS 335 0.0323
152 LEUKOENCEPHALOPATHY 120 0.0322
153 CLOSTRIDIUM DIFFICILE COLITIS 340 0.0320
154 THERAPEUTIC PRODUCT EFFECT DECREASED 1423 0.0317
155 HYPERTRIGLYCERIDAEMIA 184 0.0314
156 FOOT DEFORMITY 348 0.0314
157 DRUG SPECIFIC ANTIBODY PRESENT 203 0.0312
158 FREQUENT BOWEL MOVEMENTS 842 0.0311
159 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 531 0.0309
160 DISCOMFORT 1883 0.0308
161 ERYTHEMA NODOSUM 108 0.0307
162 STOMATITIS 1860 0.0306
163 NIGHT SWEATS 988 0.0306
164 WHEEZING 1816 0.0306
165 HIP ARTHROPLASTY 467 0.0305
166 JOINT DISLOCATION 318 0.0301
167 DRUG LEVEL DECREASED 299 0.0293
168 C-REACTIVE PROTEIN INCREASED 1060 0.0291
169 OSTEOARTHRITIS 1231 0.0290
170 ESCHERICHIA BACTERAEMIA 68 0.0289
171 KOUNIS SYNDROME 65 0.0286
172 ENTERITIS 183 0.0286
173 INFUSION SITE REACTION 85 0.0284
174 CYTOMEGALOVIRUS VIRAEMIA 126 0.0283
175 TEMPERATURE REGULATION DISORDER 63 0.0283
176 GINGIVAL PAIN 222 0.0279
177 SPONDYLITIS 101 0.0277
178 BACTERIAL INFECTION 512 0.0274
179 OESOPHAGEAL CANDIDIASIS 109 0.0273
180 APHTHOUS ULCER 212 0.0273
181 SWELLING 2526 0.0270
182 BLOOD PRESSURE DIASTOLIC INCREASED 124 0.0268
183 KLEBSIELLA INFECTION 135 0.0267
184 INFLAMMATION 1363 0.0264
185 HYPERCAPNIA 78 0.0259
186 SYSTEMIC CANDIDA 65 0.0259
187 RHINITIS 208 0.0258
188 OEDEMA 1385 0.0255
189 MOBILITY DECREASED 1830 0.0254
190 HYPERNATRAEMIA 126 0.0253
191 TASTE DISORDER 512 0.0252
192 MATERNAL EXPOSURE DURING PREGNANCY 2244 0.0252
193 STAPHYLOCOCCAL SEPSIS 124 0.0251
194 BLOOD CULTURE POSITIVE 75 0.0250
195 VENOUS THROMBOSIS 98 0.0249
196 LARGE INTESTINAL ULCER 66 0.0243
197 OXYGEN SATURATION ABNORMAL 69 0.0243
198 ROAD TRAFFIC ACCIDENT 1017 0.0243
199 INJURY 1706 0.0242
200 ENTEROCOCCAL INFECTION 117 0.0242
201 BODY TEMPERATURE DECREASED 238 0.0242
202 EPILEPSY 727 0.0238
203 COLITIS ULCERATIVE 1063 0.0238
204 DRUG INTOLERANCE 2288 0.0237
205 ORAL CANDIDIASIS 310 0.0235
206 IRON DEFICIENCY 105 0.0233
207 CARDIAC MURMUR 202 0.0233
208 SLEEP DISORDER 1646 0.0233
209 PAROSMIA 175 0.0232
210 WEIGHT FLUCTUATION 242 0.0231
211 MUCOSAL INFLAMMATION 603 0.0230
212 MYOSITIS 206 0.0229
213 LUNG DISORDER 1125 0.0229
214 FEBRILE NEUTROPENIA 1501 0.0226
215 NEUTROPENIC SEPSIS 161 0.0225
216 HYPOPHOSPHATAEMIA 166 0.0224
217 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
218 LIVER FUNCTION TEST INCREASED 475 0.0221
219 GENERAL PHYSICAL HEALTH DETERIORATION 2545 0.0220
220 MUSCULOSKELETAL STIFFNESS 1920 0.0219
221 ADVERSE REACTION 290 0.0218
222 IMPAIRED QUALITY OF LIFE 313 0.0217
223 ILL-DEFINED DISORDER 1322 0.0217
224 KNEE ARTHROPLASTY 457 0.0217
225 DELIRIUM 752 0.0216
226 BACTERIAL SEPSIS 70 0.0215
227 ESCHERICHIA SEPSIS 62 0.0214
228 HEART RATE DECREASED 750 0.0213
229 NEOPLASM RECURRENCE 72 0.0212
230 DRUG-INDUCED LIVER INJURY 666 0.0212
231 TREATMENT FAILURE 1739 0.0210
232 JOINT SWELLING 2533 0.0210
233 EXPOSURE DURING PREGNANCY 1304 0.0210
234 RHEUMATOID ARTHRITIS 2376 0.0209
235 DERMATITIS EXFOLIATIVE GENERALISED 72 0.0207
236 RECTAL HAEMORRHAGE 885 0.0206
237 GRAFT VERSUS HOST DISEASE 148 0.0206
238 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 104 0.0205
239 THERAPY NON-RESPONDER 923 0.0205
240 ANAL FISTULA 109 0.0204
241 SKIN ATROPHY 117 0.0203
242 INFUSION SITE EXTRAVASATION 125 0.0201
243 LIVER DISORDER 890 0.0200
244 GROWTH RETARDATION 59 0.0200
245 MUSCULOSKELETAL PAIN 1049 0.0200
246 HERPES SIMPLEX 130 0.0200
247 HEPATIC CIRRHOSIS 373 0.0198
248 SUSPECTED OFF LABEL USE 89 0.0197
249 RESPIRATORY ACIDOSIS 77 0.0196
250 BLOOD PRESSURE SYSTOLIC INCREASED 377 0.0193
251 SEPTIC SHOCK 840 0.0193
252 FISTULA 217 0.0193
253 EAR INFECTION 513 0.0193
254 GENERAL SYMPTOM 144 0.0192
255 PROCTALGIA 123 0.0191
256 PSEUDOMONAS INFECTION 163 0.0190
257 HEART RATE IRREGULAR 427 0.0189
258 VAGINAL DISCHARGE 191 0.0189
259 RESPIRATORY RATE INCREASED 167 0.0188
260 DRY MOUTH 1520 0.0187
261 MULTIPLE ORGAN DYSFUNCTION SYNDROME 530 0.0187
262 EAR PAIN 360 0.0185
263 CONDITION AGGRAVATED 5570 0.0183
264 MUCOUS STOOLS 90 0.0182
265 HYPOALBUMINAEMIA 141 0.0181
266 GASTROINTESTINAL DISORDER 1621 0.0181
267 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 171 0.0179
268 HYPERTRANSAMINASAEMIA 124 0.0178
269 STAPHYLOCOCCAL BACTERAEMIA 77 0.0177
270 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 297 0.0175
271 BLOOD URIC ACID INCREASED 100 0.0173
272 AORTIC STENOSIS 60 0.0172
273 ABDOMINAL DISCOMFORT 2854 0.0170
274 VENOOCCLUSIVE LIVER DISEASE 84 0.0170
275 BACTERAEMIA 200 0.0168
276 DYSPEPSIA 1655 0.0168
277 SINUSITIS 1723 0.0168
278 PARAESTHESIA ORAL 242 0.0168
279 RED CELL DISTRIBUTION WIDTH INCREASED 69 0.0166
280 RALES 96 0.0165
281 MIGRAINE 1578 0.0165
282 SPINAL FUSION SURGERY 67 0.0165
283 PNEUMOCYSTIS JIROVECII PNEUMONIA 165 0.0164
284 CANDIDA INFECTION 277 0.0164
285 HYPERBILIRUBINAEMIA 169 0.0163
286 RESPIRATORY DISORDER 488 0.0163
287 NEPHROGENIC ANAEMIA 75 0.0162
288 ANAL ABSCESS 87 0.0161
289 SKIN INFECTION 179 0.0159
290 TOXIC EPIDERMAL NECROLYSIS 242 0.0159
291 JOINT STIFFNESS 418 0.0159
292 APPENDICITIS 148 0.0158
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 759 0.0158
294 CONTUSION 1509 0.0157
295 BODY TEMPERATURE INCREASED 319 0.0156
296 OSTEOPOROSIS 638 0.0155
297 PAPULE 109 0.0155
298 URTICARIA 2576 0.0154
299 COLITIS 581 0.0153
300 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1079 0.0152
301 HYPERSENSITIVITY 2797 0.0151
302 CARDIOGENIC SHOCK 216 0.0150
303 ENCEPHALITIS 103 0.0149
304 ECZEMA 776 0.0148
305 DISABILITY 292 0.0148
306 UVEITIS 200 0.0147
307 HYPERTENSION 3117 0.0147
308 TUMOUR LYSIS SYNDROME 129 0.0146
309 HEPATITIS 370 0.0144
310 CONFUSIONAL STATE 2323 0.0144
311 PREGNANCY 287 0.0143
312 HYDROCEPHALUS 78 0.0143
313 HYPOAESTHESIA 2123 0.0142
314 VIRAL INFECTION 467 0.0140
315 SKIN PLAQUE 118 0.0140
316 SKIN WARM 81 0.0139
317 ATELECTASIS 134 0.0139
318 INFECTION 2000 0.0138
319 ABSCESS 219 0.0137
320 HYPONATRAEMIA 773 0.0137
321 ALOPECIA 2693 0.0137
322 HAEMATOCHEZIA 754 0.0136
323 BLOOD THYROID STIMULATING HORMONE DECREASED 62 0.0136
324 BACK DISORDER 221 0.0136
325 ARTERIOSCLEROSIS CORONARY ARTERY 90 0.0136
326 MACULAR DEGENERATION 162 0.0136
327 BENIGN PROSTATIC HYPERPLASIA 70 0.0135
328 TUBULOINTERSTITIAL NEPHRITIS 254 0.0135
329 CLOSTRIDIUM DIFFICILE INFECTION 295 0.0135
330 POLYARTHRITIS 71 0.0135
331 HYPOKALAEMIA 620 0.0134
332 VENTRICULAR FIBRILLATION 149 0.0134
333 ACUTE RESPIRATORY DISTRESS SYNDROME 237 0.0134
334 ORAL DISORDER 98 0.0134
335 ARTHRITIS INFECTIVE 62 0.0134
336 WEIGHT INCREASED 2991 0.0133
337 MEDICATION ERROR 741 0.0133
338 VASCULAR DEVICE INFECTION 60 0.0132
339 THERAPEUTIC RESPONSE SHORTENED 437 0.0132
340 NEURALGIA 318 0.0131
341 VAGINAL INFECTION 61 0.0129
342 HYPOVOLAEMIC SHOCK 62 0.0129
343 PERIPHERAL SWELLING 1967 0.0128
344 NASOPHARYNGITIS 2347 0.0127
345 DEFAECATION URGENCY 89 0.0127
346 FAILURE TO THRIVE 65 0.0125
347 INFLAMMATORY MARKER INCREASED 62 0.0125
348 DRUG LEVEL INCREASED 206 0.0124
349 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2233 0.0124
350 MYASTHENIA GRAVIS 100 0.0124
351 INFUSION SITE SWELLING 77 0.0122
352 PRODUCT USE ISSUE 2289 0.0122
353 SEPSIS 1338 0.0120
354 ENDOCARDITIS 61 0.0119
355 OXYGEN SATURATION DECREASED 663 0.0118
356 ACIDOSIS 90 0.0118
357 HYPERLIPIDAEMIA 140 0.0117
358 PYREXIA 4053 0.0117
359 TROPONIN INCREASED 89 0.0117
360 DRUG TOLERANCE 59 0.0117
361 BLOOD LACTIC ACID INCREASED 61 0.0116
362 HAEMODYNAMIC INSTABILITY 88 0.0115
363 RASH 5031 0.0115
364 HAEMORRHOIDS 225 0.0115
365 RESPIRATORY DISTRESS 318 0.0115
366 STREPTOCOCCAL INFECTION 64 0.0115
367 SKIN LESION 315 0.0115
368 ASTHMA 1293 0.0114
369 INFUSION SITE PAIN 147 0.0114
370 UPPER RESPIRATORY TRACT INFECTION 525 0.0114
371 AMNESIA 739 0.0113
372 DIARRHOEA HAEMORRHAGIC 106 0.0113
373 TACHYPNOEA 154 0.0113
374 TACHYCARDIA 1004 0.0113
375 SKIN SWELLING 98 0.0113
376 ACUTE RESPIRATORY FAILURE 217 0.0113
377 ARTHRITIS 885 0.0112
378 PULMONARY HAEMORRHAGE 88 0.0112
379 LUNG INFILTRATION 99 0.0112
380 TENDERNESS 116 0.0111
381 ENCEPHALOPATHY 273 0.0111
382 CYTOKINE RELEASE SYNDROME 223 0.0111
383 ENTEROCOLITIS 64 0.0111
384 PRODUCT ADMINISTRATION INTERRUPTED 87 0.0111
385 NEUROTOXICITY 194 0.0111
386 ORAL HERPES 216 0.0111
387 OFF LABEL USE 9687 0.0111
388 MOUTH ULCERATION 233 0.0110
389 OBSTRUCTIVE AIRWAYS DISORDER 123 0.0110
390 RASH PRURITIC 598 0.0110
391 DISSEMINATED INTRAVASCULAR COAGULATION 155 0.0110
392 IMPAIRED WORK ABILITY 235 0.0110
393 PRODUCT USE IN UNAPPROVED INDICATION 2723 0.0110
394 THROMBOTIC MICROANGIOPATHY 107 0.0110
395 ANAPHYLACTIC REACTION 605 0.0109
396 ESCHERICHIA INFECTION 90 0.0109
397 SKIN HYPERPIGMENTATION 94 0.0109
398 HYPERGLYCAEMIA 398 0.0109
399 SKIN FISSURES 213 0.0109
400 NECK PAIN 607 0.0109
401 DERMATITIS 226 0.0108
402 SWOLLEN TONGUE 336 0.0107
403 GASTROENTERITIS 156 0.0107
404 HYPOXIA 376 0.0107
405 POLYURIA 87 0.0106
406 MULTI-ORGAN FAILURE 183 0.0106
407 MOUTH SWELLING 61 0.0106
408 ARTHRALGIA 4391 0.0105
409 APPETITE DISORDER 70 0.0105
410 HYDRONEPHROSIS 79 0.0105
411 CONCOMITANT DISEASE AGGRAVATED 65 0.0105
412 STAPHYLOCOCCAL INFECTION 347 0.0105
413 GASTROOESOPHAGEAL REFLUX DISEASE 840 0.0104
414 BLOOD PRESSURE INCREASED 1588 0.0104
415 FEELING HOT 636 0.0104
416 MALNUTRITION 116 0.0104
417 CYTOMEGALOVIRUS INFECTION 172 0.0103
418 NEUROLOGICAL SYMPTOM 59 0.0103
419 LIPASE INCREASED 79 0.0103
420 SKIN LACERATION 112 0.0103
421 PALLOR 280 0.0103
422 LOWER GASTROINTESTINAL HAEMORRHAGE 76 0.0103
423 RESPIRATORY FAILURE 749 0.0103
424 ELECTROLYTE IMBALANCE 119 0.0102
425 INFUSION SITE ERYTHEMA 86 0.0102
426 END STAGE RENAL DISEASE 186 0.0102
427 RASH ERYTHEMATOUS 486 0.0102
428 TOOTH INFECTION 134 0.0102
429 MUSCULAR WEAKNESS 1150 0.0101
430 ABDOMINAL PAIN 2346 0.0101
431 COAGULOPATHY 168 0.0101
432 DECREASED APPETITE 2323 0.0100
433 PRURITUS 3836 0.0100
434 SINUS TACHYCARDIA 141 0.0099
435 ASPHYXIA 81 0.0099
436 HYPERTHYROIDISM 143 0.0099
437 ABDOMINAL DISTENSION 1031 0.0099
438 FUNGAL INFECTION 329 0.0099
439 IMMUNOSUPPRESSION 87 0.0099
440 MYOPATHY 85 0.0098
441 ASCITES 289 0.0098
442 LYMPHOPENIA 139 0.0098
443 CHEST PAIN 1815 0.0098
444 TYPE 1 DIABETES MELLITUS 59 0.0098
445 SCRATCH 103 0.0098
446 PARAESTHESIA 1534 0.0097
447 SLEEP APNOEA SYNDROME 186 0.0097
448 PANCYTOPENIA 543 0.0097
449 PHARYNGITIS STREPTOCOCCAL 105 0.0097
450 ADVERSE DRUG REACTION 868 0.0097
451 OEDEMA PERIPHERAL 1176 0.0096
452 WEIGHT DECREASED 2692 0.0096
453 ABDOMINAL PAIN UPPER 1984 0.0096
454 OSTEOPENIA 145 0.0095
455 PERIPHERAL COLDNESS 131 0.0095
456 PANCREATITIS 504 0.0095
457 ASPIRATION 104 0.0095
458 URINE OUTPUT DECREASED 83 0.0095
459 FEELING COLD 263 0.0094
460 LOW BIRTH WEIGHT BABY 75 0.0094
461 SKIN EXFOLIATION 795 0.0094
462 LEFT VENTRICULAR DYSFUNCTION 63 0.0094
463 CELLULITIS 472 0.0094
464 GENERALISED OEDEMA 115 0.0093
465 CYANOSIS 146 0.0093
466 PNEUMONIA 3002 0.0093
467 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 95 0.0092
468 ANAL INCONTINENCE 83 0.0092
469 HEPATIC CYTOLYSIS 117 0.0092
470 HYPOGAMMAGLOBULINAEMIA 60 0.0091
471 RASH MACULO-PAPULAR 203 0.0091
472 MUSCLE SPASTICITY 112 0.0091
473 MEMORY IMPAIRMENT 1247 0.0091
474 CORONAVIRUS INFECTION 60 0.0091
475 RESPIRATORY SYNCYTIAL VIRUS INFECTION 79 0.0091
476 FLANK PAIN 85 0.0091
477 CROHN'S DISEASE 62 0.0090
478 HEPATOCELLULAR INJURY 128 0.0090
479 ORAL PAIN 202 0.0090
480 VASCULITIS 105 0.0090
481 BOWEL MOVEMENT IRREGULARITY 69 0.0090
482 EJECTION FRACTION DECREASED 140 0.0090
483 DIVERTICULUM 64 0.0090
484 HYPERCALCAEMIA 111 0.0090
485 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 67 0.0089
486 HAEMATOCRIT DECREASED 176 0.0089
487 ERYTHEMA 1824 0.0089
488 BLOOD SODIUM DECREASED 167 0.0089
489 CIRCULATORY COLLAPSE 149 0.0087
490 SKIN REACTION 123 0.0087
491 IRON DEFICIENCY ANAEMIA 80 0.0087
492 PRODUCTIVE COUGH 413 0.0086
493 TOOTH ABSCESS 88 0.0086
494 WHITE BLOOD CELL COUNT INCREASED 331 0.0086
495 BRONCHOSPASM 123 0.0086
496 PNEUMONIA BACTERIAL 79 0.0086
497 HYPOTHERMIA 87 0.0086
498 DERMATITIS CONTACT 98 0.0086
499 BLOOD MAGNESIUM DECREASED 74 0.0086
500 TRICUSPID VALVE INCOMPETENCE 68 0.0086
501 VOMITING 4005 0.0085
502 DEVICE RELATED INFECTION 131 0.0085
503 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 70 0.0085
504 ULCER 135 0.0085
505 MALAISE 3697 0.0084
506 OROPHARYNGEAL PAIN 780 0.0084
507 OESOPHAGITIS 92 0.0084
508 PLEURAL EFFUSION 511 0.0084
509 FAECES SOFT 61 0.0084
510 CYSTITIS 267 0.0084
511 CHEST DISCOMFORT 854 0.0083
512 ADVERSE EVENT 767 0.0083
513 HYPOTENSION 1666 0.0083
514 GASTROINTESTINAL INFLAMMATION 65 0.0083
515 CHOLESTASIS 159 0.0083
516 THROMBOCYTOPENIA 924 0.0083
517 UNRESPONSIVE TO STIMULI 213 0.0082
518 SKIN DISORDER 275 0.0082
519 SCAB 94 0.0082
520 RASH PUSTULAR 60 0.0082
521 PREMATURE DELIVERY 131 0.0082
522 BLOOD CALCIUM INCREASED 72 0.0082
523 INTESTINAL PERFORATION 92 0.0082
524 BLOOD ALBUMIN DECREASED 65 0.0082
525 GOUT 147 0.0082
526 INSOMNIA 2181 0.0082
527 PAIN IN EXTREMITY 2407 0.0082
528 PANCREATITIS ACUTE 183 0.0081
529 MUSCLE SPASMS 1494 0.0081
530 CARDIOMEGALY 100 0.0081
531 DEPRESSION 1844 0.0081
532 DEEP VEIN THROMBOSIS 526 0.0081
533 CONJUNCTIVITIS 150 0.0081
534 SPINAL OSTEOARTHRITIS 71 0.0081
535 HAEMOPTYSIS 225 0.0081
536 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 439 0.0080
537 HYPOTHYROIDISM 255 0.0080
538 SEASONAL ALLERGY 113 0.0080
539 RHINORRHOEA 516 0.0080
540 ACUTE KIDNEY INJURY 1218 0.0080
541 ERYTHEMA MULTIFORME 74 0.0079
542 CHILLS 925 0.0079
543 POST PROCEDURAL INFECTION 64 0.0079
544 HYPERTHERMIA 60 0.0079
545 FATIGUE 6093 0.0078
546 HYPERKALAEMIA 273 0.0078
547 RASH MACULAR 272 0.0078
548 DYSPNOEA 4401 0.0078
549 GAIT DISTURBANCE 1487 0.0078
550 GAMMA-GLUTAMYLTRANSFERASE INCREASED 172 0.0078
551 PSORIASIS 1006 0.0077
552 PULMONARY EMBOLISM 729 0.0077
553 HYPOCALCAEMIA 145 0.0077
554 LUNG INFECTION 119 0.0077
555 PULMONARY MASS 114 0.0076
556 PNEUMONITIS 207 0.0076
557 GASTROINTESTINAL INFECTION 68 0.0076
558 SECRETION DISCHARGE 95 0.0076
559 PERICARDIAL EFFUSION 175 0.0076
560 LIP SWELLING 252 0.0076
561 ANURIA 65 0.0075
562 THROAT TIGHTNESS 204 0.0075
563 HEART RATE INCREASED 747 0.0075
564 OROPHARYNGEAL DISCOMFORT 68 0.0075
565 STATUS EPILEPTICUS 85 0.0075
566 POLYNEUROPATHY 90 0.0075
567 THROAT IRRITATION 337 0.0075
568 ASTHENIA 2821 0.0075
569 PYELONEPHRITIS 65 0.0075
570 PHARYNGITIS 93 0.0075
571 DERMATITIS ATOPIC 395 0.0075
572 SKIN HAEMORRHAGE 111 0.0075
573 SPUTUM DISCOLOURED 71 0.0075
574 DERMATITIS ALLERGIC 94 0.0075
575 EMBOLISM 62 0.0075
576 LABORATORY TEST ABNORMAL 220 0.0074
577 TRANSFUSION 78 0.0074
578 STEVENS-JOHNSON SYNDROME 165 0.0074
579 INTESTINAL OBSTRUCTION 279 0.0074
580 HYPOGLYCAEMIA 359 0.0074
581 NERVE COMPRESSION 68 0.0074
582 FACE OEDEMA 124 0.0073
583 PAIN 4512 0.0073
584 BLOOD IRON DECREASED 87 0.0073
585 INCONTINENCE 77 0.0073
586 BRONCHITIS 539 0.0073
587 THERAPEUTIC RESPONSE DECREASED 441 0.0073
588 BLOOD PRESSURE DECREASED 483 0.0073
589 HYPOMAGNESAEMIA 101 0.0072
590 IMMUNODEFICIENCY 108 0.0072
591 RENAL TUBULAR NECROSIS 71 0.0072
592 HEADACHE 4529 0.0072
593 TRANSAMINASES INCREASED 160 0.0072
594 FLUSHING 726 0.0071
595 SPINAL COMPRESSION FRACTURE 59 0.0071
596 INJECTION SITE REACTION 491 0.0071
597 NEUTROPHIL COUNT INCREASED 73 0.0071
598 FLUID RETENTION 362 0.0071
599 DIARRHOEA 4568 0.0071
600 SMALL INTESTINAL OBSTRUCTION 87 0.0071
601 SHOCK 162 0.0070
602 EMPHYSEMA 71 0.0070
603 SINUS BRADYCARDIA 68 0.0070
604 FOOT FRACTURE 133 0.0070
605 LYMPHADENOPATHY 248 0.0070
606 SKIN ULCER 181 0.0070
607 JOINT INJURY 149 0.0070
608 LEUKOCYTOSIS 126 0.0070
609 TINNITUS 319 0.0069
610 ILEUS 86 0.0069
611 ANKLE FRACTURE 107 0.0069
612 ANGIOEDEMA 305 0.0069
613 CYST 85 0.0068
614 NEUROPATHY PERIPHERAL 651 0.0068
615 BONE MARROW FAILURE 139 0.0068
616 RESPIRATORY TRACT INFECTION 178 0.0068
617 UROSEPSIS 63 0.0068
618 LEUKOPENIA 341 0.0068
619 METABOLIC ACIDOSIS 218 0.0068
620 PNEUMOTHORAX 108 0.0068
621 BRAIN OEDEMA 86 0.0068
622 ANAEMIA 1287 0.0067
623 GASTROENTERITIS VIRAL 121 0.0067
624 BACK PAIN 1556 0.0067
625 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 172 0.0067
626 FLUID OVERLOAD 97 0.0067
627 CHOLECYSTITIS 79 0.0066
628 ALANINE AMINOTRANSFERASE INCREASED 407 0.0066
629 BLOOD TEST ABNORMAL 93 0.0066
630 HEPATOTOXICITY 147 0.0066
631 CONSTIPATION 1439 0.0066
632 PROCEDURAL PAIN 183 0.0066
633 SWELLING FACE 429 0.0066
634 HIDRADENITIS 60 0.0066
635 RED BLOOD CELL COUNT DECREASED 188 0.0066
636 FOETAL EXPOSURE DURING PREGNANCY 533 0.0066
637 NASAL CONGESTION 384 0.0065
638 CYTOPENIA 80 0.0065
639 ACCIDENTAL OVERDOSE 239 0.0065
640 NAUSEA 5129 0.0065
641 PREMATURE BABY 195 0.0065
642 PNEUMONIA ASPIRATION 161 0.0064
643 ASPARTATE AMINOTRANSFERASE INCREASED 342 0.0064
644 COVID-19 PNEUMONIA 76 0.0064
645 PHOTOPHOBIA 121 0.0064
646 BLOOD CREATININE INCREASED 418 0.0064
647 MICTURITION URGENCY 73 0.0064
648 PAIN IN JAW 181 0.0064
649 ORTHOSTATIC HYPOTENSION 111 0.0064
650 COVID-19 1115 0.0063
651 EYE DISCHARGE 66 0.0063
652 DEHYDRATION 845 0.0063
653 BLOOD UREA INCREASED 106 0.0063
654 NEPHROLITHIASIS 290 0.0063
655 CHRONIC KIDNEY DISEASE 480 0.0063
656 URINARY TRACT INFECTION 1076 0.0063
657 NEUTROPENIA 857 0.0063
658 DRY SKIN 839 0.0063
659 ANXIETY 1785 0.0063
660 DIZZINESS 3125 0.0063
661 QUALITY OF LIFE DECREASED 84 0.0063
662 BLOOD LACTATE DEHYDROGENASE INCREASED 99 0.0062
663 TOOTHACHE 113 0.0062
664 HEPATIC FAILURE 188 0.0062
665 ATAXIA 74 0.0062
666 BLOOD CALCIUM DECREASED 70 0.0062
667 EYE INFECTION 70 0.0062
668 MYOCARDITIS 71 0.0062
669 INCORRECT PRODUCT ADMINISTRATION DURATION 134 0.0062
670 EYE INFLAMMATION 59 0.0062
671 COUGH 1734 0.0062
672 EYE SWELLING 230 0.0062
673 VERTIGO 376 0.0062
674 SUPRAVENTRICULAR TACHYCARDIA 59 0.0062
675 BASAL CELL CARCINOMA 96 0.0061
676 SPINAL PAIN 72 0.0061
677 PULMONARY OEDEMA 275 0.0061
678 PHARYNGEAL SWELLING 60 0.0061
679 NIGHTMARE 212 0.0061
680 VENTRICULAR TACHYCARDIA 100 0.0060
681 LETHARGY 348 0.0060
682 BRADYCARDIA 320 0.0060
683 CARDIOMYOPATHY 89 0.0060
684 DRUG TOXICITY 82 0.0060
685 MUSCULOSKELETAL CHEST PAIN 93 0.0060
686 PRESYNCOPE 146 0.0060
687 GASTRITIS 158 0.0060
688 LOCALISED INFECTION 145 0.0060
689 ANAPHYLACTIC SHOCK 154 0.0060
690 HYPOAESTHESIA ORAL 90 0.0060
691 LACRIMATION INCREASED 180 0.0060
692 RENAL FAILURE 791 0.0060
693 LYMPHOCYTE COUNT DECREASED 105 0.0059
694 ABDOMINAL PAIN LOWER 150 0.0059
695 BLOOD BILIRUBIN INCREASED 160 0.0059
696 GENERALISED TONIC-CLONIC SEIZURE 98 0.0059
697 HYPOTONIA 59 0.0059
698 MENTAL STATUS CHANGES 164 0.0059
699 UNDERDOSE 431 0.0059
700 TOOTH FRACTURE 65 0.0059
701 RENAL FAILURE ACUTE 250 0.0059
702 SUBARACHNOID HAEMORRHAGE 60 0.0059
703 RASH PAPULAR 132 0.0059
704 TENDONITIS 91 0.0059
705 SKIN DISCOLOURATION 267 0.0058
706 EYE PRURITUS 195 0.0058
707 DRUG INEFFECTIVE 7645 0.0058
708 HAEMOGLOBIN DECREASED 593 0.0058
709 POOR QUALITY SLEEP 124 0.0058
710 OSTEOMYELITIS 104 0.0057
711 MYOCARDIAL ISCHAEMIA 65 0.0057
712 THERAPY PARTIAL RESPONDER 89 0.0057
713 LACTIC ACIDOSIS 184 0.0057
714 KIDNEY INFECTION 111 0.0057
715 DYSPNOEA EXERTIONAL 213 0.0056
716 PETECHIAE 59 0.0056
717 DYSURIA 208 0.0056
718 BLOOD ALKALINE PHOSPHATASE INCREASED 140 0.0056
719 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 294 0.0056
720 PULMONARY HYPERTENSION 117 0.0056
721 PALPITATIONS 656 0.0056
722 AGRANULOCYTOSIS 104 0.0056
723 NODULE 73 0.0056
724 INFLUENZA 622 0.0056
725 POST PROCEDURAL COMPLICATION 107 0.0056
726 VISUAL IMPAIRMENT 689 0.0056
727 HAEMORRHAGE INTRACRANIAL 83 0.0055
728 CARDIAC ARREST 455 0.0055
729 DYSPHAGIA 523 0.0055
730 COLD SWEAT 97 0.0055
731 INFLUENZA LIKE ILLNESS 452 0.0055
732 BURNING SENSATION 383 0.0055
733 MYOCLONUS 65 0.0054
734 DISEASE RECURRENCE 258 0.0054
735 HEPATIC STEATOSIS 101 0.0054
736 RESPIRATORY TRACT CONGESTION 86 0.0054
737 HERPES ZOSTER 310 0.0054
738 SOMNOLENCE 1086 0.0054
739 MITRAL VALVE INCOMPETENCE 61 0.0054
740 PHOTOSENSITIVITY REACTION 89 0.0054
741 RESTLESS LEGS SYNDROME 98 0.0054
742 BLOOD POTASSIUM DECREASED 162 0.0054
743 BRAIN FOG 84 0.0054
744 ILLNESS 551 0.0053
745 CAESAREAN SECTION 62 0.0053
746 PULMONARY CONGESTION 70 0.0053
747 REBOUND EFFECT 60 0.0053
748 RHABDOMYOLYSIS 221 0.0053
749 OCULAR HYPERAEMIA 251 0.0053
750 PAIN OF SKIN 142 0.0053
751 EOSINOPHILIA 92 0.0052
752 EYELID OEDEMA 61 0.0052
753 ACUTE MYOCARDIAL INFARCTION 154 0.0052
754 ALTERED STATE OF CONSCIOUSNESS 113 0.0052
755 SEIZURE 602 0.0052
756 TREATMENT NONCOMPLIANCE 285 0.0052
757 THYROID DISORDER 80 0.0052
758 HIATUS HERNIA 67 0.0052
759 ECONOMIC PROBLEM 78 0.0051
760 OSTEONECROSIS 169 0.0051
761 EYE DISORDER 169 0.0051
762 NEOPLASM 59 0.0051
763 DIABETES MELLITUS 391 0.0051
764 SNEEZING 115 0.0051
765 GALLBLADDER DISORDER 91 0.0051
766 INTERNATIONAL NORMALISED RATIO INCREASED 145 0.0051
767 HYPOPHAGIA 130 0.0051
768 NEUTROPHIL COUNT DECREASED 205 0.0050
769 DRUG INTERACTION 790 0.0050
770 HEMIPARESIS 84 0.0050
771 SINUS DISORDER 98 0.0049
772 ANHEDONIA 130 0.0049
773 INTERVERTEBRAL DISC PROTRUSION 108 0.0049
774 DRY EYE 245 0.0049
775 GLAUCOMA 94 0.0049
776 RASH GENERALISED 126 0.0049
777 INSURANCE ISSUE 74 0.0048
778 DISEASE PROGRESSION 572 0.0048
779 HYPERHIDROSIS 621 0.0048
780 HAEMATEMESIS 122 0.0048
781 PROTEINURIA 91 0.0048
782 HAEMATOMA 124 0.0048
783 NERVOUS SYSTEM DISORDER 149 0.0048
784 MELAENA 105 0.0048
785 TOOTH DISORDER 106 0.0048
786 BLOOD TRIGLYCERIDES INCREASED 84 0.0047
787 ACUTE MYELOID LEUKAEMIA 74 0.0047
788 APHONIA 66 0.0047
789 FLATULENCE 267 0.0047
790 IMPAIRED GASTRIC EMPTYING 64 0.0047
791 BONE PAIN 275 0.0047
792 PLATELET COUNT INCREASED 61 0.0047
793 DEPRESSED LEVEL OF CONSCIOUSNESS 185 0.0047
794 LIMB INJURY 127 0.0047
795 EPISTAXIS 349 0.0047
796 BONE DISORDER 85 0.0047
797 URINARY INCONTINENCE 138 0.0047
798 DYSPHONIA 272 0.0046
799 DYSGEUSIA 345 0.0046
800 CARPAL TUNNEL SYNDROME 65 0.0046
801 BEDRIDDEN 61 0.0046
802 FEEDING DISORDER 94 0.0046
803 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 108 0.0046
804 BLOOD POTASSIUM INCREASED 75 0.0046
805 RIB FRACTURE 95 0.0046
806 SCAR 79 0.0046
807 ACUTE HEPATIC FAILURE 63 0.0046
808 LIVER FUNCTION TEST ABNORMAL 134 0.0046
809 MYALGIA 782 0.0046
810 SINUS CONGESTION 62 0.0046
811 CHOLELITHIASIS 149 0.0045
812 DIPLOPIA 118 0.0045
813 SYNCOPE 454 0.0045
814 HEAD DISCOMFORT 80 0.0045
815 HERNIA 87 0.0045
816 FAECES DISCOLOURED 97 0.0045
817 HOT FLUSH 337 0.0045
818 DIVERTICULITIS 123 0.0044
819 PLATELET COUNT DECREASED 473 0.0044
820 CORONARY ARTERY DISEASE 134 0.0044
821 APHASIA 133 0.0044
822 PERITONITIS 91 0.0044
823 SPINAL FRACTURE 88 0.0044
824 NEOPLASM PROGRESSION 152 0.0044
825 FALL 1447 0.0043
826 LOSS OF CONSCIOUSNESS 556 0.0043
827 DYSARTHRIA 163 0.0043
828 DIABETIC KETOACIDOSIS 104 0.0043
829 DISORIENTATION 171 0.0043
830 RETCHING 92 0.0043
831 SKIN BURNING SENSATION 309 0.0043
832 RENAL IMPAIRMENT 361 0.0043
833 EATING DISORDER 91 0.0043
834 LIMB DISCOMFORT 132 0.0043
835 CATARACT 254 0.0043
836 GASTRIC ULCER 81 0.0043
837 THIRST 76 0.0042
838 CARDIO-RESPIRATORY ARREST 177 0.0042
839 PRODUCT PRESCRIBING ISSUE 92 0.0042
840 MASS 59 0.0042
841 DRUG ERUPTION 74 0.0042
842 CHROMATURIA 94 0.0042
843 DRUG RESISTANCE 106 0.0041
844 POLLAKIURIA 172 0.0041
845 HALLUCINATION, VISUAL 87 0.0041
846 ATRIAL FIBRILLATION 400 0.0041
847 SKIN CANCER 88 0.0041
848 THROMBOSIS 328 0.0041
849 URINARY RETENTION 136 0.0041
850 MUSCULOSKELETAL DISCOMFORT 70 0.0041
851 BLOOD URINE PRESENT 77 0.0041
852 MUSCLE TWITCHING 93 0.0040
853 HYPERSOMNIA 115 0.0040
854 ISCHAEMIC STROKE 71 0.0040
855 ELECTROCARDIOGRAM QT PROLONGED 143 0.0040
856 UPPER LIMB FRACTURE 79 0.0040
857 DISTURBANCE IN ATTENTION 213 0.0039
858 PRODUCT ADMINISTRATION ERROR 79 0.0039
859 PRODUCT PRESCRIBING ERROR 93 0.0039
860 BLOOD PRESSURE ABNORMAL 77 0.0039
861 DYSSTASIA 113 0.0039
862 EYE PAIN 218 0.0039
863 PRODUCT QUALITY ISSUE 524 0.0039
864 PHARYNGEAL OEDEMA 59 0.0038
865 SPEECH DISORDER 200 0.0038
866 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0038
867 TREMOR 631 0.0038
868 PRURITUS GENERALISED 82 0.0038
869 HAEMORRHAGE 395 0.0038
870 FULL BLOOD COUNT DECREASED 76 0.0038
871 GASTROINTESTINAL HAEMORRHAGE 315 0.0038
872 MOVEMENT DISORDER 121 0.0038
873 HEAD INJURY 119 0.0038
874 INTENTIONAL PRODUCT MISUSE 324 0.0037
875 RESPIRATORY ARREST 102 0.0037
876 HEPATIC FUNCTION ABNORMAL 138 0.0037
877 MIDDLE INSOMNIA 69 0.0037
878 CEREBRAL HAEMORRHAGE 132 0.0037
879 CARDIAC FAILURE 290 0.0036
880 AGITATION 265 0.0036
881 RESTLESSNESS 132 0.0036
882 MENTAL DISORDER 156 0.0036
883 WHITE BLOOD CELL COUNT DECREASED 388 0.0036
884 INTENTIONAL DOSE OMISSION 102 0.0036
885 PRODUCT DOSE OMISSION IN ERROR 101 0.0036
886 HAEMATURIA 122 0.0036
887 TRANSIENT ISCHAEMIC ATTACK 120 0.0036
888 VISION BLURRED 486 0.0035
889 INCORRECT DOSE ADMINISTERED 806 0.0035
890 DEPRESSED MOOD 186 0.0035
891 SKIN IRRITATION 160 0.0035
892 PSYCHOTIC DISORDER 102 0.0035
893 THINKING ABNORMAL 64 0.0034
894 MALIGNANT NEOPLASM PROGRESSION 351 0.0034
895 IRRITABILITY 206 0.0034
896 JAUNDICE 91 0.0034
897 BLINDNESS 137 0.0034
898 PELVIC PAIN 61 0.0034
899 CHOKING 65 0.0033
900 BALANCE DISORDER 286 0.0033
901 INCREASED APPETITE 62 0.0032
902 PRODUCT DOSE OMISSION ISSUE 940 0.0032
903 SEROTONIN SYNDROME 61 0.0032
904 INTERSTITIAL LUNG DISEASE 153 0.0032
905 PANIC ATTACK 115 0.0032
906 DEMENTIA 88 0.0031
907 FEELING ABNORMAL 754 0.0031
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
909 HYPOACUSIS 132 0.0031
910 AGEUSIA 76 0.0030
911 COMA 145 0.0030
912 OSTEONECROSIS OF JAW 75 0.0030
913 INJECTION SITE PRURITUS 203 0.0030
914 RENAL INJURY 90 0.0030
915 CRYING 110 0.0030
916 ANGINA PECTORIS 86 0.0030
917 HOSPITALISATION 461 0.0030
918 CONVULSION 171 0.0030
919 CARDIAC FAILURE CONGESTIVE 240 0.0030
920 THERAPEUTIC RESPONSE UNEXPECTED 131 0.0029
921 CEREBROVASCULAR ACCIDENT 494 0.0029
922 DEAFNESS 76 0.0029
923 HALLUCINATION 219 0.0029
924 NERVOUSNESS 151 0.0029
925 MOOD SWINGS 92 0.0029
926 CEREBRAL INFARCTION 70 0.0029
927 EYE IRRITATION 164 0.0028
928 SURGERY 163 0.0028
929 PLASMA CELL MYELOMA 108 0.0028
930 PRODUCT SUBSTITUTION ISSUE 159 0.0028
931 WITHDRAWAL SYNDROME 115 0.0027
932 ARRHYTHMIA 129 0.0027
933 HIP FRACTURE 87 0.0027
934 ACNE 205 0.0027
935 AGGRESSION 135 0.0027
936 MENTAL IMPAIRMENT 65 0.0027
937 INJECTION SITE URTICARIA 64 0.0026
938 COGNITIVE DISORDER 120 0.0026
939 MOOD ALTERED 70 0.0026
940 DYSKINESIA 103 0.0025
941 DEVICE DISLOCATION 109 0.0025
942 OVERDOSE 538 0.0025
943 INJECTION SITE RASH 74 0.0024
944 BONE DENSITY DECREASED 75 0.0024
945 RENAL DISORDER 110 0.0024
946 BLOOD GLUCOSE DECREASED 113 0.0024
947 FEMUR FRACTURE 72 0.0023
948 NEOPLASM MALIGNANT 154 0.0023
949 GASTRIC DISORDER 79 0.0023
950 SUICIDAL IDEATION 210 0.0023
951 DEVICE BREAKAGE 93 0.0023
952 APPLICATION SITE ERYTHEMA 60 0.0023
953 TOXICITY TO VARIOUS AGENTS 380 0.0023
954 EXPIRED PRODUCT ADMINISTERED 74 0.0022
955 EMOTIONAL DISTRESS 268 0.0022
956 DRUG DOSE OMISSION BY DEVICE 166 0.0021
957 DRUG EXPOSURE DURING PREGNANCY 72 0.0021
958 EMOTIONAL DISORDER 65 0.0021
959 ABORTION SPONTANEOUS 84 0.0021
960 ABNORMAL BEHAVIOUR 83 0.0021
961 DEVICE LEAKAGE 89 0.0021
962 THERAPY INTERRUPTED 145 0.0020
963 MYELOSUPPRESSION 73 0.0020
964 UNEVALUABLE EVENT 152 0.0020
965 CARDIAC DISORDER 186 0.0020
966 VISUAL ACUITY REDUCED 66 0.0020
967 INJECTION SITE ERYTHEMA 242 0.0019
968 INJECTION SITE SWELLING 149 0.0019
969 BLOOD GLUCOSE INCREASED 363 0.0019
970 INJECTION SITE BRUISING 152 0.0019
971 DEATH 1625 0.0019
972 MYOCARDIAL INFARCTION 315 0.0018
973 PRODUCT DOSE OMISSION 116 0.0018
974 DEVICE MALFUNCTION 120 0.0017
975 INJECTION SITE PAIN 517 0.0017
976 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 76 0.0016
977 DRUG EFFECT DECREASED 87 0.0016
978 NO ADVERSE EVENT 279 0.0015
979 DEVICE ISSUE 136 0.0015
980 THERAPY CESSATION 75 0.0015
981 MULTIPLE SCLEROSIS 69 0.0014
982 SUICIDE ATTEMPT 82 0.0014
983 DRUG DOSE OMISSION 199 0.0012
984 INTENTIONAL OVERDOSE 76 0.0012
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
986 INJECTION SITE HAEMORRHAGE 85 0.0011
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 208 0.0010
988 DRUG DEPENDENCE 152 0.0009
989 ACCIDENTAL EXPOSURE TO PRODUCT 88 0.0009
990 BREAST CANCER 76 0.0008
991 DRUG WITHDRAWAL SYNDROME 67 0.0008